A PHASE 3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER

StatusActive
Effective start/end date13/04/1713/04/21

Funding

  • Pfizer, Inc.: $56,590.59

Keywords

  • Biotechnology & Drug Development, Immunology